High-protein diet and exercise for people starting tirzepatide
Part of Hormones & metabolism clinical trials.
This study tests whether adding a high-protein diet and resistance training (strength exercises) helps people taking tirzepatide (Zepbound/Mounjaro) lose fat while keeping muscle. You will receive nutrition counseling and may be asked to do strength training twice a week.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 60 years old
- Your BMI is between 27 and 37
- You are about to start tirzepatide, or you started it within the last 4 weeks
- You have not lost more than 3% of your weight in the last month
- You are willing to follow a high-protein diet and attend nutrition sessions via video
- You can do strength training twice a week and have an MRI at the start and after 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
This study tests if tirzepatide (a weight loss drug) can help women and men with early-stage hormone receptor-positive breast cancer who are overweight or obese. The goal is to see if losing weight can improve outcomes after completing their initial breast cancer treatment.
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This trial tests the weight‑loss medication tirzepatide (Mounjaro) in people who are overweight or have obesity and have stable coronary artery disease. The goal is to see if tirzepatide can reduce dangerous fatty plaque in heart arteries.
This study looks at whether adding a structured exercise program to the weight-loss medication tirzepatide can improve muscle health and physical function in people who are overweight or obese. Participants will exercise while taking their usual medication, and the researchers will measure muscle quality and strength.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.